Satellite communications company Viasat (VSAT -4.37%) posted an unexpected quarterly loss, though the company's free cash flow was significantly better than expected.Investors are focused on the headline number, sending Viasat shares down as much as 8% at the open and down 3% as of 10:15 a.m. ET. A work in progressViasat lost $0.02 per share in its fiscal fourth quarter, ended March 31, on revenue of $1.15 billion, compared to Wall Street's expectations for a $0.04-per-share profit on slightly lower revenue ...

Core Insights - Palo Alto Networks Inc (NASDAQ:PANW) shares are down 6.2% to $182.52 following the fiscal third-quarter results, where profits exceeded estimates, revenue met expectations, but gross margin fell more than anticipated [1] - The company has forecasted a strong current quarter and raised its full-year guidance [1] Analyst Reactions - Four analysts have reduced their price targets, with Northland Capital lowering it to $177 from $210, while Wells Fargo increased its target to $235 from $225 and maintained an "overweight" rating [2] - The stock has experienced significant volatility, trading between a high of $208.39 on February 19 and a low of $144.15 on April 7, currently at its lowest level since late April [2] Market Activity - The stock's 14-day relative strength index (RSI) is at 70.9, indicating it is in "overbought" territory, suggesting a potential short-term drop [3] - There has been a notable increase in options trading, with 72,000 calls and 48,000 puts traded, which is ten times the typical volume, with the weekly 5/23 180-strike put being the most popular [3]

Core Viewpoint - Apogee Therapeutics Inc. (APGE) has shown a significant price increase of 13.6% over the past four weeks, with a mean price target of $93.88 indicating a potential upside of 132.7% from the current price of $40.34 [1] Price Targets - The average price target consists of eight estimates ranging from a low of $78 to a high of $116, with a standard deviation of $11.05, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a potential increase of 93.4%, while the most optimistic estimate suggests an upside of 187.6% [2] Analyst Consensus and Earnings Estimates - Analysts are increasingly optimistic about APGE's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has historically correlated with stock price movements [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 9.2%, with three estimates moving higher and no negative revisions [12] Zacks Rank - APGE currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, which supports the stock's potential upside [13]

Core Viewpoint - North American Construction (NOA) has shown a significant price increase of 11.1% over the past four weeks, with a mean price target of $25.70 indicating a potential upside of 51.1% from its current price of $17.01 [1] Price Targets and Analyst Consensus - The average price target for NOA ranges from a low of $19.46 to a high of $31.68, with a standard deviation of $3.99, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a 14.4% increase, while the highest suggests an 86.2% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts are optimistic about NOA's earnings prospects, as indicated by a trend of upward revisions in earnings estimates [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1.3%, with one estimate moving higher and no negative revisions [12] - NOA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - Investors should treat price targets with skepticism and not rely solely on them for investment decisions [10]

Core Viewpoint - Olema Pharmaceuticals, Inc. (OLMA) shows significant upside potential with a mean price target of $24.71, indicating a 386.4% increase from the current price of $5.08 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $18 to a high of $30, with a standard deviation of $4.64, suggesting variability in analyst opinions [2] - The lowest estimate indicates a potential increase of 254.3%, while the highest suggests a 490.6% upside [2] - A low standard deviation indicates a higher agreement among analysts regarding price movement [9] Analyst Sentiment - Analysts are optimistic about OLMA's earnings prospects, as indicated by a positive trend in earnings estimate revisions [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 25.4%, with five estimates moving higher and no negative revisions [12] Zacks Rank - OLMA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting strong potential for upside [13]

Oatly Group AB Sponsored ADR (OTLY) closed the last trading session at $10.26, gaining 18.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $18.74 indicates an 82.7% upside potential.The average comprises seven short-term price targets ranging from a low of $10.20 to a high of $40, with a standard deviation of $10.52. While the lowest estimate indicates a decline of 0.6% from the ...

Group 1 - Shift4 Payments (FOUR) shares have increased by 17.2% over the past four weeks, closing at $90.26, with a mean price target of $114.83 indicating a potential upside of 27.2% [1] - The average of 23 short-term price targets ranges from a low of $80 to a high of $150, with a standard deviation of $15.53, suggesting variability in analyst estimates [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 20.2% over the past month [11][12] Group 2 - FOUR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - The correlation between earnings estimate revisions and near-term stock price movements supports the expectation of an upside in FOUR [11] - While price targets are often viewed skeptically, the direction implied by the consensus price target may serve as a useful guide for potential price movement [10][13]

Shares of Septerna, Inc. (SEPN) have gained 57.8% over the past four weeks to close the last trading session at $9.42, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $23.67 indicates a potential upside of 151.3%.The average comprises three short-term price targets ranging from a low of $18 to a high of $28, with a standard deviation of $5.13. While the lowest estimate indicates ...

Silence Therapeutics PLC Sponsored ADR (SLN) closed the last trading session at $5.14, gaining 68.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $35.50 indicates a 590.7% upside potential.The average comprises six short-term price targets ranging from a low of $3 to a high of $75, with a standard deviation of $23.86. While the lowest estimate indicates a decline of 41.6% from t ...

SharkNinja, Inc. (SN) closed the last trading session at $100.59, gaining 35.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $126.06 indicates a 25.3% upside potential.The average comprises nine short-term price targets ranging from a low of $101 to a high of $175, with a standard deviation of $21.94. While the lowest estimate indicates an increase of 0.4% from the current price ...